TNIK and synovial sarcoma: Transfection of three siRNA constructs targeting TNIK (siTNIK#1, #2, and #3) into HS-SY-II and SYO-1 synovial sarcoma cells was confirmed to reduce the levels of TNIK gene expression relative to cells transfected with control siRNA (Ctrl) (Figure 2A).